Enzalutamide Plus ADT for the Treatment of mHSPC: Real-World Evidence from a Bulgarian Cohort.

Manova M, Ivanova B, Rangelov A, Petrova M, Dudov A, Chan I, Ahmed S, Nenov V, Varbanova E, Georgiev T, Penchev D, Savova A

Open source

DOI: 10.3390/cancers18183007
Published: 2026 Sep 16
Container: Cancers
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers18183007,
  title = {Enzalutamide Plus ADT for the Treatment of mHSPC: Real-World Evidence from a Bulgarian Cohort.},
  author = {Manova M and Ivanova B and Rangelov A and Petrova M and Dudov A and Chan I and Ahmed S and Nenov V and Varbanova E and Georgiev T and Penchev D and Savova A},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18183007},
  url = {https://doi.org/10.3390/cancers18183007}
}

RIS

TY  - JOUR
TI  - Enzalutamide Plus ADT for the Treatment of mHSPC: Real-World Evidence from a Bulgarian Cohort.
AU  - Manova M
AU  - Ivanova B
AU  - Rangelov A
AU  - Petrova M
AU  - Dudov A
AU  - Chan I
AU  - Ahmed S
AU  - Nenov V
AU  - Varbanova E
AU  - Georgiev T
AU  - Penchev D
AU  - Savova A
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18183007
UR  - https://doi.org/10.3390/cancers18183007
ER  -

APA

M, M., B, I., A, R., M, P., A, D., I, C., S, A., V, N., E, V., T, G., D, P., & A, S. (2026). Enzalutamide Plus ADT for the Treatment of mHSPC: Real-World Evidence from a Bulgarian Cohort.. Cancers. https://doi.org/10.3390/cancers18183007

Source records

pubmed · retrieved 2026-09-27T07:50:16.500Z